Prawo i regulacje · 26/08/2014

Patheon Pharmaceuticals, Inc. Receives DEA Registration for Controlled Substance Manufacturing

The US Department of Justice's Drug Enforcement Administration (DEA) has granted Patheon Pharmaceuticals, Inc. a registration to manufacture a specific class of controlled substances, following a formal application by the company.